Administration of Chemotherapeutic Agents

Similar documents
Department Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual

SARASOTA MEMORIAL HOSPITAL

Policies and Procedures. RNSP: RN Procedure. I.D. Number: 1067

HAZARDOUS DRUGS: HANDLING PRECAUTIONS BACKGROUND PURPOSE POLICY STATEMENTS

This course was written for RN.ORG by an outside consultant and RN.ORG has rights for distribution but is not responsible for the contents.

SARASOTA MEMORIAL HOSPITAL

To provide a safe environment for individuals involved in handling and administration of hazardous drugs.

SAFE HANDLING OF HAZARDOUS MEDICATIONS (CYTOTOXIC AND NON-CYTOTOXIC) POLICY

CENTRAL IOWA HEALTHCARE Marshalltown, Iowa

Policy for Handling the Spillage of Cytotoxic and Anti-Cancer Drugs

MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa

ISOLATION TABLE OF CONTENTS STANDARD PRECAUTIONS... 2 CONTACT PRECAUTIONS... 4 DROPLET PRECAUTIONS... 6 ISOLATION PROCEDURES... 7

HomeMed Information. for the UMHS Cancer Center

Home+ Home+ Home Infusion. Home Infusion. regionalhealth.org/home

STANDARD PRECAUTIONS POLICY Page 1 of 8 Reviewed: May 2017

& ADDITIONAL PRECAUTIONS:

CAPE ELIZABETH SCHOOL DEPARTMENT Cape Elizabeth, Maine

STANDARDIZED PROCEDURE HEPATIC ARTERY INFUSION OF CHEMOTHERAPY (Adults, Peds)

Sterile Compounding of Hazardous Drugs

Table of Contents. Nursing Skills. Page 2 of 8. Nursing School Made Simple Guaranteed 2014 SimpleNursing.com All Rights Reserved.

MSAD 55. Blood Borne Pathogens Control Plan. 137 South Hiram Road Hiram, Maine (207)

Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework

How to use your Mitomycin C eye drops % or 0.02%

Medication Administration Using the Home Pump (Eclipse)

Guidance for the Selection and Use of Personal Protective Equipment (PPE) in Healthcare Settings

Berinert Home Infusion Program. By: Loris Aro RN INNOMAR STRATEGIES

Principles of Infection Prevention and Control

Standard Precautions

Oregon Health & Science University Department of Surgery Standard Precautions Policy

DISTRICT NURSING and INTERMEDIATE CARE

CORPORATE SAFETY MANUAL

Systemic anti-cancer therapy Care Pathway

Unit 4 Administration of Cancer Systemic Therapy

Hazardous Drugs. Controlling the risk in healthcare facilities. By Joseph W. Klancher, Mary Vorndran and William Weiss

Toolkit for Safe Handling of Hazardous Drugs for Nurses in Oncology

ENDORSED BY THE GOVERNANCE COMMITTEE

Welcome to Risk Management

Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever

Wyoming STATE BOARD OF NURSING

EAST CAROLINA UNIVERSITY INFECTION CONTROL POLICY

St. Vincent s East Page 1 of 5

THE VALLEY HOSPITAL Ridgewood, New Jersey PATIENT CARE SERVICES POLICY AND PROCEDURE

1. Infection Control, Centers for Disease Control and Prevention (CDC). (2002). Guideline for hand hygiene in health-care settings

Etoposide (VePesid ) ( e-toe-poe-side )

Chapter 10. medical and Surgical Asepsis. safe, effective Care environment. Practices that Promote Medical Asepsis

While Your Child Is on the BMT Unit

Abiraterone Acetate (Zytiga )

Intravenous Medication Administration via a Central Venous Line

Health Workers Working Healthy: Personal Protective Equipment

PHYSICIAN PRACTICE ENHANCEMENT PROGRAM Assessment Standards. Infection Prevention and Control: Personal Protective Equipment

Student Guidelines for Preventing Occupational Exposure to Bloodborne Pathogens (BBP)

Burn Intensive Care Unit

Bloodborne Pathogens & Exposure Control Plan

Bloodborne Pathogens Exposure Control Plan. Approved by The College at Brockport, Office of Environmental Health and Safety, February 2018

MODULE 22: Contingency Planning and Emergency Response to Healthcare Waste Spills

8/3/2010. Influencing factors Staffing Personal / social Work flow Physical environment Organizational factors

Cobimetinib (Cotellic ) ( koe-bi-me-ti-nib )

BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN

The Safe Prescribing, Handling and Administration of Cytotoxic Drugs

201 KAR 20:490. Licensed practical nurse intravenous therapy scope of practice.

Professional Practice and Patient Safety Council

Infection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases

RESEARCH LABORATORIES CONDUCTING HIV/HBV RESEARCH AND PRODUCTION

IV 03 CRAIG HOSPITAL POLICY/PROCEDURE

To provide information about the role of the pharmacy in Infection Prevention and Control.

Ebola guidance package

DISEASE TRANSMISSION PRECAUTIONS AND PERSONAL PROTECTIVE EQUIPMENT (PPE)

Nursing care standards for cancer patients undergoing chemotherapy.

PROVINCIAL GUIDELINES FOR THE SAFE HANDLING, ADMINISTRATION AND DISPOSAL OF ANTINEOPLASTIC AGENTS

Some Exposure: There could be occupational exposure, but not as a part of their normal work routine.

Multiple Chemical Sensitivities Care of Patients With

Step 1A: Before entering patient room, be sure you have all the material ready and available:

Infection Control Safety Guidance Document

Manhattan Fire Protection District

Chemotherapy Administration Policy

CHEMOTHERAPY/HAZARDOUS DRUGS PRECAUTIONS, PREPARATION, ORDERING

Exposure Controls A. The agency provides equipment and supplies that protect employees from bloodborne pathogen

Infection Control Policy and Procedure Manual. Post-Anesthesia Care Unit (Recovery Room) Page 1 of 6

NBCP PO C Administration of injections

Disposing of Medical Waste A Quick-Reference Guide

TABLE OF CONTENTS. Page 1 of 21

[] PERSONAL PROTECTIVE EQUIPMENT Vol. 13, No. 8 August 2009

Administering Cytarabine to Children in the Community Setting

NEEDLE STICK SAFETY & BLOODBORNE PATHOGENS (BBP)

60 KNEES ROAD, PARK ORCHARDS, VICTORIA 3114

Safety Policy and Procedure

Everyone Involved in providing healthcare should adhere to the principals of infection control.

Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure

If viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.

Personal Hygiene & Protective Equipment. NEO111 M. Jorgenson, RN BSN

First Aid Policy. Appletree Treatment Centre

BLOOD AND BODILY FLUID GUIDELINES

Application of eye drops

#29 & #30 MEASURING INTAKE AND OUTPUT/WOUND DRAINAGE SYSTEMS (TEST)

BLOOD-BORNE PATHOGENS EXPOSURE PROTOCOL OFF-CAMPUS CLINICAL EXPERIENCES STUDENT PROCEDURES

PC EP 4; PC EP 7. (Outpatient Only) If nutritional screen positive, plans for follow-up documented.

INFECTION CONTROL POLICY DATE: 03/01/01 REVISED: 7/15/09 STATEMENT

SURVEY ON THE PRODUCTION AND PREPARATION OF CYTOSTATIC DRUGS

BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN

Infection Control: You are the Expert

Transcription:

Administration of Chemotherapeutic Agents Contributed by The Outer Banks Hospital Nags Head, NC Leading Practices Library Organizations submit practices to The Joint Commission that they have found to be leading practices, with permission to share them with other organizations. The Joint Commission makes these leading practices available to organizations that may wish to examine their applicability to their particular circumstances. Please understand that The Joint Commission can make no representations as to the results that any organization can expect from their use or adaptation of a leading practice to their particular circumstances. 4/16/2010 1

SUBJECT: Administration of Chemotherapeutic agents NUMBER: A-91 ORIG: 12/08 REVIEWED: 06/09 REVISED: 06/09 RESPONSIBLE PARTY: PREPARED BY: APPROVED BY: PURPOSE To safely administer chemotherapeutic agents and dispose of the articles used for chemotherapy. POLICY Chemotherapeutic drugs may be administered by registered nurses who have been competency checked in the Administration of Chemotherapy. Preparation and Teaching: Explain the procedure to the patient. Assemble equipment: IV Pump IV Start Kit or Central line Kit for ports Huber Needle or Small gauge IV needle Secondary set Primary tubing 250cc Normal saline Preinfusion: 1. Drug order written by MD. Chemo Tag initiated. 2. Order reviewed and calculated by RN and signed. Verifies height, weight, and allergies. 3. Order and Chemo Tag sent to pharmacy. Copy of order made and placed in Chemotherapy administration book. Original filed in chart. 4. Pharmacist verifies order. 5. Pharmacist enters order into order entry system. 6. Pharmacist verifies Pharmacy Dispensing Record with original handwritten order. 7. Pharmacist prepares the order. 8. Drug delivered to oncology. 1 2

9. Nurse verifies with the pharmacist against original order; Implementation: 1. Review drug information, as needed. 2. Confirms patient s identity using 2 identifiers. Name and date of birth ( medical record number and Acct number are to be placed in appropriate space on Chemo Tag). Patient will have name band applied per Hospital ID policy. 3. Access IV site. Avoid use of the antecubital area. 4. Assure that IV is patent by infusing with NS or appropriate solution. Use an IV pump for continuous infusion. NOTE: Continuous infusions of vesicants are administered through central venous lines. 5. Give pre-medication (usually an antiemetic), if ordered. 6. Two Nurses verify Pt name, DOB, MR#, ACCT #, Medication and dose. 7. Apply PPE. 8. Connect primed secondary container and line to primary tubing. a. Patient to report immediately any change in sensation particularly pain, burning or stinging. 9. Administer medication according to physician s orders, observing for signs of infiltration, local redness or swelling. 10. Dispose of bottles, gloves, tubing, needles and any other items used for chemotherapy in appropriate chemo waste container. 11. Wear gloves while handling chemotherapy items and patient s linen. Linen contaminated with urine, feces, blood or vomitus must be handled with particular care, because chemotherapeutic agents are excreted in body secretions. (See additional information for treatment of contamination and spills). 12. Give post-medication(s), usually antiemetics and diuretics, if ordered by physician/np. 2 3

Documentation: 1. Record chemotherapeutic agent, dosage, route of administration and type and the amount of IV fluid in EMR for patient. 2. Complete appropriate information throughout form and document in computer. 3. Complete LDA Docflow sheet in EMR. 4. Make all documentation entries in medical record according to policies and procedures. Additional Information: 1. Use extreme caution to protect yourself and others from contact with chemotherapeutic agents. If contamination does occur, treat as follows: a. Immediately remove the gloves, mask, and/or gown. b. Wash the affected skin area immediately with soap (not germicidal cleaner) and water. For eye exposure, immediately flush the eye for five minutes with water or isotonic eyewash designated for that purpose. c. Report exposure immediately to Occupational Health Nurse. 2. Avoid spills of chemotherapeutic agents. If spills of less than 30 ml occur: a. Employees will always wear personal protective equipment when cleaning up a spill. For example, gowns, double powder-free latex gloves, and splash goggles. b. Liquid spills will be cleaned up by the use of designated absorbent gauze pads. c. Solid spills will be wiped with wet absorbent mats. d. Dispose of all materials in appropriate chemo waste container. e. The spill area will be cleaned three times using a detergent solution followed by clean water. f. Obtain Chemo Spill Kit for clean up of spills greater than 30 ml. 3. Chemotherapy drugs will be administered in the order written, unless otherwise specified by the physician. 3 4

4. The nurse stays with the patient the entire time a vesicant is administered through peripheral line. 5. Encourage P.O. intake of fluids for chemotherapy patients unless contraindicated. *List of Vesicants Carmustine Esorubicin Vinblastine Cerubidine Etoposide Vincristine Cisplatin 5-Fluorouracil Vindesive Dacarbazine Idarubicin Vinorelbine Dactinomycin Mechlorethamine Oxaliplatin Daunorubicin Doxorubicine Epirubicin Mitomycin Plicamycin Porfiromycin * Refer to ONS Chemotherapy and Biotherapy Guidelines and Recommendations for Practice, for any vesicants, and irritants and the appropriate treatment for each. 4 5